World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
59445
World Ranking
2000
National Ranking
1138

Roger J. Packer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roger J. Packer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 727 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Roger J. Packer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roger J. Packer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 136 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Roger J. Packer is affiliated with Children's National Health System in the United States and has contributed extensively to the field of medical research, focusing primarily on neurological and genetic conditions. Their research portfolio encompasses work on glioma diagnosis and treatment, neuroblastoma, neurofibromatosis, schwannoma, and related brain tumor conditions.

Their recent publications include studies across various reputable venues:

  • "Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation" (2021, Genetics in Medicine)
  • "Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours" (2022, Nature Reviews Neurology)
  • "Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes" (2020, Cancer Discovery)
  • "Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation" (2022, Genetics in Medicine)
  • "The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications" (2021, Neuro-Oncology)

Their frequent coauthors include:

  • Lindsay Kilburn
  • Javad Nazarian
  • Miriam Bornhorst
  • Michael J. Fisher
  • Maryam Fouladi

Publication venues where Roger J. Packer has contributed regularly include:

  • Neuro-Oncology (64 publications)
  • Journal of Clinical Oncology (8 publications)
  • Neuro-Oncology Advances (7 publications)
  • Journal of Neuro-Oncology (5 publications)
  • UNC Libraries (5 publications)

Their primary field of study is Medicine, with a strong focus on overlapping subfields such as Genetics, Neurology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Epidemiology.

Key research topics within their work encompass:

  • Glioma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Neurofibromatosis and Schwannoma Cases
  • Meningioma and schwannoma management
  • Chromatin Remodeling and Cancer
  • Brain Metastases and Treatment
  • Radiomics and Machine Learning in Medical Imaging

Best Publications

  • Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

    Lucy Balian Rorke;Roger J. Packer;Jaclyn A. Biegel

  • Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

    Roger J. Packer;Amar Gajjar;Gilbert Vezina;Lucy Rorke-Adams

  • Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study

    Paul M. Zeltzer;James M. Boyett;Jonathan L. Finlay;A. Leland Albright

  • Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.

    Leslie L. Robison;Ann C. Mertens;John D. Boice;Norman E. Breslow

  • Treatment of Children With Medulloblastomas With Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group Study

    Roger J. Packer;Joel Goldwein;H. Stacy Nicholson;L. Gilbert Vezina

  • The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research

    Leslie L. Robison;Gregory T. Armstrong;John D. Boice;Eric J. Chow

  • Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas

    Roger J. Packer;Joanne Ater;Jeffrey Allen;Peter Phillips

  • Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

    Vijay Ramaswamy;Marc Remke;Eric Bouffet;Simon Bailey

  • New Primary Neoplasms of the Central Nervous System in Survivors of Childhood Cancer: a Report From the Childhood Cancer Survivor Study

    Joseph P. Neglia;Leslie L. Robison;Marilyn Stovall;Yan Liu

  • Intellectual Outcome After Reduced-Dose Radiation Therapy Plus Adjuvant Chemotherapy for Medulloblastoma: A Children’s Cancer Group Study

    M. Douglas Ris;Roger Packer;Joel Goldwein;Dana Jones-Wallace

  • Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.

    Gregory T. Armstrong;Qi Liu;Yutaka Yasui;Sujuan Huang

  • Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force.

    R Listernick;DN Louis;RJ Packer;DH Gutmann

  • Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy

    Packer Rj;Sutton Ln;Elterman R;Lange B

  • Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

    Tobey J. MacDonald;Kevin M. Brown;Kevin M. Brown;Bonnie Lafleur;Katia Peterson

  • Psychological Outcomes in Long-Term Survivors of Childhood Brain Cancer: A Report From the Childhood Cancer Survivor Study

    Brad J. Zebrack;James G. Gurney;Kevin Oeffinger;John Whitton

  • Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings

    Lisa Diller;Eric J. Chow;James G. Gurney;Melissa M. Hudson

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

    E Legius;L Messiaen;P Wolkenstein;P Pancza

  • A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results.

    Roger J. Packer;Leslie N. Sutton;Thomas E. Atkins;Jerilynn Radcliffe

  • Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood cancer survivor study

    James G. Gurney;M.S.P.H. Nina S. Kadan-Lottick M.D.;Roger J. Packer;M.P.H. Joseph P. Neglia M.D.

  • Carboplatin and Vincristine Chemotherapy for Children with Newly Diagnosed Progressive Low-Grade Gliomas

    R J Packer;J Ater;J Allen;P Phillips

Frequent Co-Authors

Leslie N. Sutton
Leslie N. Sutton University of Pennsylvania
Lucy B. Rorke
Lucy B. Rorke Children's Hospital of Philadelphia
Michael Fisher
Michael Fisher University of Manchester
Ian F. Pollack
Ian F. Pollack University of Pittsburgh
James M. Boyett
James M. Boyett St. Jude Children's Research Hospital
Eric Bouffet
Eric Bouffet University of Toronto
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Amar Gajjar
Amar Gajjar St. Jude Children's Research Hospital
Robert A. Zimmerman
Robert A. Zimmerman Children's Hospital of Philadelphia
Mark W. Kieran
Mark W. Kieran Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA isn’t just limited to becoming a physician. There are many rewarding online degree and career opportunities in related health fields. If you’re interested in leadership and management within healthcare, healthcare administration degrees provide a strong foundation for roles in hospital administration or clinical management.

For those seeking to advance further, pursuing one of the cheapest mha programs can offer a cost-effective way to boost qualifications and career prospects in health management. Nursing professionals may consider dnp online programs cheap to move into advanced clinical or leadership roles.

If pharmacy is your area of interest, there are accessible online pharmd programs designed to provide the necessary skills and credentials to succeed in pharmaceutical careers. Each of these online pathways offers flexibility, affordability, and opportunities for advancement in the healthcare field, making them excellent alternatives or supplements to traditional medical education in the USA.

Best Scientists Citing Roger J. Packer

Trending Scientists

Recently Published Articles